Veterinary drug,industry,In january 2017,the escherichia coli project of hebei kexing pharmaceutical CO. ,LTD had passed the approval of agricultural transgenic biology safety. This project was launched in early 2013,then in turn passed the biological intermediate test, environmental release test and biosafety test within after 4 years.
The escherichia coli project passed the approval meaning the local government expert institutions fully affirmed for our company’s research and development capabilities and achievements in recent years.in the future, we will increase our innovation and make the technology center becoming a research platform for new products and new technologies. We will become a platform for attracting and pooling scientific and technological talents, mobilizing and developing its enthusiasm and creativity. To strengthen cooperation in production and research, in accordance with the “Benefit sharing, risk sharing” Principle for development of new products and new technologies, the establishment of research institutes and laboratories, co-training of technical personnel will provide our customers with better service and help.
Post time: Feb-01-2021